In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011

Rationale: Surgical lung biopsy can help to determine a specific diagnosis in interstitial lung disease, but has associated risks. Most currently available mortality data are derived from case series and may not be generalizable to broader populations. Objectives: We aimed to assess in-hospita...

Full description

Bibliographic Details
Main Authors: Hutchinson, John P., Fogarty, Andrew W., McKeever, Tricia M., Hubbard, Richard B.
Format: Article
Published: American Thoracic Society 2016
Subjects:
Online Access:https://eprints.nottingham.ac.uk/32623/
_version_ 1848794451732856832
author Hutchinson, John P.
Fogarty, Andrew W.
McKeever, Tricia M.
Hubbard, Richard B.
author_facet Hutchinson, John P.
Fogarty, Andrew W.
McKeever, Tricia M.
Hubbard, Richard B.
author_sort Hutchinson, John P.
building Nottingham Research Data Repository
collection Online Access
description Rationale: Surgical lung biopsy can help to determine a specific diagnosis in interstitial lung disease, but has associated risks. Most currently available mortality data are derived from case series and may not be generalizable to broader populations. Objectives: We aimed to assess in-hospital mortality following surgical lung biopsy for interstitial lung disease in a national secondary care dataset from the United States. Methods: Data were obtained from the 2000-2011 Nationwide Inpatient Sample. Cases were identified using International Classification of Diseases (ICD-9-CM) codes for interstitial lung disease and surgical lung biopsies. Lung resections and cases of lung cancer were excluded. Weighted data were used to estimate numbers of biopsies nationwide and in-hospital mortality, and multivariable logistic regression was used to adjust for sex, age, geographic region, co-morbidity, type of operation and provisional diagnosis. Measurements and Main Results: We estimated there to be around 12,000 surgical lung biopsies performed annually for interstitial lung disease in the United States, two-thirds of which were performed electively. In-hospital mortality was 1.7% for elective procedures, but significantly higher for non-elective procedures (16.0%). Male sex, increasing age, increasing co-morbidity, open surgery and a provisional diagnosis of idiopathic pulmonary fibrosis or connective tissue disease related interstitial lung disease were risk factors for increased mortality. Conclusions: In-hospital mortality following elective surgical lung biopsy for interstitial lung disease is just under 2%, but significantly higher for non-elective procedures. Identified risk factors for death should be taken into account when counselling patients on whether to pursue a histological diagnosis.
first_indexed 2025-11-14T19:16:24Z
format Article
id nottingham-32623
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:16:24Z
publishDate 2016
publisher American Thoracic Society
recordtype eprints
repository_type Digital Repository
spelling nottingham-326232020-05-04T17:51:51Z https://eprints.nottingham.ac.uk/32623/ In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011 Hutchinson, John P. Fogarty, Andrew W. McKeever, Tricia M. Hubbard, Richard B. Rationale: Surgical lung biopsy can help to determine a specific diagnosis in interstitial lung disease, but has associated risks. Most currently available mortality data are derived from case series and may not be generalizable to broader populations. Objectives: We aimed to assess in-hospital mortality following surgical lung biopsy for interstitial lung disease in a national secondary care dataset from the United States. Methods: Data were obtained from the 2000-2011 Nationwide Inpatient Sample. Cases were identified using International Classification of Diseases (ICD-9-CM) codes for interstitial lung disease and surgical lung biopsies. Lung resections and cases of lung cancer were excluded. Weighted data were used to estimate numbers of biopsies nationwide and in-hospital mortality, and multivariable logistic regression was used to adjust for sex, age, geographic region, co-morbidity, type of operation and provisional diagnosis. Measurements and Main Results: We estimated there to be around 12,000 surgical lung biopsies performed annually for interstitial lung disease in the United States, two-thirds of which were performed electively. In-hospital mortality was 1.7% for elective procedures, but significantly higher for non-elective procedures (16.0%). Male sex, increasing age, increasing co-morbidity, open surgery and a provisional diagnosis of idiopathic pulmonary fibrosis or connective tissue disease related interstitial lung disease were risk factors for increased mortality. Conclusions: In-hospital mortality following elective surgical lung biopsy for interstitial lung disease is just under 2%, but significantly higher for non-elective procedures. Identified risk factors for death should be taken into account when counselling patients on whether to pursue a histological diagnosis. American Thoracic Society 2016-05-15 Article PeerReviewed Hutchinson, John P., Fogarty, Andrew W., McKeever, Tricia M. and Hubbard, Richard B. (2016) In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011. American Journal of Respiratory and Critical Care Medicine, 193 (10). pp. 1161-1167. ISSN 1535-4970 Interstitial lung disease Mortality Surgery http://www.atsjournals.org/doi/10.1164/rccm.201508-1632OC doi:10.1164/rccm.201508-1632OC doi:10.1164/rccm.201508-1632OC
spellingShingle Interstitial lung disease
Mortality
Surgery
Hutchinson, John P.
Fogarty, Andrew W.
McKeever, Tricia M.
Hubbard, Richard B.
In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011
title In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011
title_full In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011
title_fullStr In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011
title_full_unstemmed In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011
title_short In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011
title_sort in-hospital mortality following surgical lung biopsy for interstitial lung disease in the usa: 2000-2011
topic Interstitial lung disease
Mortality
Surgery
url https://eprints.nottingham.ac.uk/32623/
https://eprints.nottingham.ac.uk/32623/
https://eprints.nottingham.ac.uk/32623/